Blended solutions gain momentum and reveal untapped potential
Promised land
Related Posts
Osivax publishes phase 2a results supporting dual flu vaccine approach
OVX836 shown to be safe and effective alongside seasonal Fluarix Tetra Osivax has released phase 2a trial data confirming that its broad-spectrum flu vaccine candidate, […]
Fiona Smith-Laittan – PharmaTimes
Fiona Smith-Laittan has been appointed Chair of Cambridge Global Health Partnerships Fiona Smith-Laittan, Vice President of Global Health Strategy and Partnerships at GlaxoSmithKline (GSK), has […]
One Biosciences raises €15 million to advance single-cell oncology platform
Funding to accelerate development of AI-driven tumour profiling tool OneMap One Biosciences has secured €15 million in Series A financing to expand its AI-powered single-cell […]